Jim O’Neill once proposed doing away with FDA's mandate of assuring new drugs are safe and effective, suggesting that could be done after they hit the market.

President Donald Trump has picked Jim O’Neill, a former investor and critic of health regulations serving under Health Secretary Robert F. Kennedy Jr., to take control of the Centers for Disease Control and Prevention, following a tumultuous week in which the agency’s director was forced out.

O’Neill, Kennedy’s deputy at the Department of Health and Human Services, will supplant Susan Monarez, a longtime government scientist who had been the CDC director for less than a month.

Monarez’s lawyers said she refused “to rubber-stamp unscientific, reckless directives and fire dedicated health experts.”

    • Basic Glitch@sh.itjust.worksOP
      13·
      12 days ago

      Who’s to say really?

      Richard Indyke, Jeffrey Epstein’s attorney and estate manager might know, but for some reason nobody really seemed to pick up on this story the Atlantic published a few weeks ago

      Parlatore told me during a brief conversation. He added that Indyke’s “experience on the legal side of the Epstein business was valuable.” For instance, Indyke knows how to structure financial arrangements and purchase aircraft, Parlatore said. “I hired him because of that.”

      Those kinds of financial skills are what the two women who sued Indyke allege were at the heart of Epstein’s criminal enterprise. In his bio, Indyke touts his experience “as general counsel to family offices, serial entrepreneurs, investors, and other ultra-high-net-worth clientele.” He doesn’t mention Epstein. Among his other capabilities: “Complex business and commercial transactions,” as well as “aviation, marine, and other exotic asset purchases, sales, and operation.”

      Last I heard democratic congressman Ro Kahnna (who is also invested in Palantir) was pushing very hard to get Richard Indyke and Epstein’s other executor (his former accountant) to testify before Congress about the Epstein birthday book. I’m sure whatever testimony they provide will be very trustworthy.

      NYT also tried to bring attention to the executors of Epstein’s estate earlier this summer bc of the millions of dollars they’re still making from the investments Epstein made with Thiel’s company.